IDO1 as a new immune biomarker for diabetic nephropathy and its correlation with immune cell infiltration.

Abstract

INTRODUCTION\nIndoleamine 2,3-dioxygenase 1(IDO1) has complicated roles in immune-inflammatory response regulation, but its correlation with immune cell infiltration in diabetic nephropathy (DN) remains unknown.\n\n\nMETHODS\nGene expression data were extracted from the GEO database. Differentially expressed genes (DEGs) were identified and functional correlation analysis was performed. The immune hub gene was screened using Maximal Clique Centrality, and verified in DN model mice via western blotting, immunohistochemistry, and immunofluorescence analysis. CIBERSORTx was used to assign values to immune cell infiltration in DN and determine a correlation with the hub gene. The prognostic significance of the hub gene was then validated.\n\n\nRESULTS\nThe 330 screened DEGs from the GEO dataset were most enriched in GO functions and KEGG pathways associated with immune inflammation. IDO1 was identified as a hub immune gene, with upregulated expression in DN model mice. IDO1 expression was positively correlated with M1 macrophages (R\xa0=\xa00.58, P\xa0<\xa00.001) and monocytes (R\xa0=\xa00.44, P\xa0=\xa00.049), and was negatively correlated with resting memory CD4 T cells (R\xa0=\xa0-0.51, P\xa0=\xa00.019). IDO1 expression was upregulated in peritoneal macrophages after high glucose stimulation, and inflammatory factor production was reversed by IDO1 inhibition. Higher IDO1 expression was associated with worse prognosis in DN patients via multivariate survival analysis (P\xa0<\xa00.001).\n\n\nCONCLUSIONS\nIDO1 was identified as a diagnostic and prognostic biomarker for DN and shown to play a vital role in immune cell infiltration in DN, ascertained using microarray data and CIBERSORTx for the first time.